ROIV

Roivant Sciences Ltd.

Healthcare · Biotechnology

$201.94 sample

+2.58 (+1.29%) 1D

Market cap

$660.1B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-28

Alerts

8

Price$201.94 +12.67% 3M daily closessample

201.94179.12

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28SECDEF 14A filed
Sep 21SEC10-Q filed
Sep 15SECDEF 14A filed
Sep 09INSInsider buy: EVP, Operations
Sep 02INSInsider sell: General Counsel
Aug 28INSInsider sell: Chief Executive Officer
Aug 25INSInsider buy: General Counsel
Aug 17SEC8-K filed: material event

Sign up to see the real ROIV record →

Company facts

SEC EDGAR registration

Name: Roivant Sciences Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +34sample, -100 to +100
Reporting currency: USD

Who is positioning in ROIV

sample

Insiders: 16 insider transactions over 90 days, net selling, $252.5M
Congress: 3 members traded over 90 days
Institutions · 13F: 24 funds hold $6.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.8B +13.3% y/y

Q4 2024Q3 2026

Inventory$21.1B +10.1% y/y

Q4 2024Q3 2026

Accounts receivable$15.9B +11.2% y/y

Q4 2024Q3 2026

Total debt$41.9B +14.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $655.2B +3.5% 3M
Sample peer B: $246.7B -10.6% 3M
Sample peer C: $206.9B +4.5% 3M
Sample peer D: $214.2B -7.4% 3M
Sample peer E: $269.3B -11.2% 3M